First Time Loading...
K

Knight Therapeutics Inc
TSX:GUD

Watchlist Manager
Knight Therapeutics Inc
TSX:GUD
Watchlist
Price: 6.11 CAD -0.49% Market Closed
Updated: May 20, 2024

EV/EBITDA
Enterprise Value to EBITDA

8.9
Current
10
Median
13.7
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
8.9
=
Enterprise Value
474.2m
/
EBITDA
53.3m
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
7.8
2-Years Forward
EV/EBITDA
6.2
3-Years Forward
EV/EBITDA
5.2

See Also

Discover More